Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advanced gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial

被引：0
|
作者：
Yan, Y. [1 ]
Lu, L. [1 ]
Wang, X. [1 ]
Wang, D. [1 ]
Huang, Q. [2 ]
Zhao, Q. [3 ]
Liu, T. [1 ]
Fu, W. [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Shanxi Prov Canc Hosp, Taiyuan, Shanxi, Peoples R China
[3] Hebei Med Univ 4 Hosp, Shijiazhuang, Hebei, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-67
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [41] Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Cho, Hyungwoo
    Park, Young Soo
    Lee, Jong Seok
    Ryu, Min-Hee
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [42] Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
    Jeong, Sang-Ho
    Kim, Rock Bum
    Oh, Sung Eun
    An, Ji Yeong
    Seo, Kyung Won
    Min, Jae-Seok
    CANCERS, 2022, 14 (16)
  • [43] Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT)
    Lee, Hyuk-Joon
    Hyung, Woo Jin
    Yang, Han-Kwang
    Han, Sang Uk
    Park, Young-Kyu
    An, Ji Yeong
    Kim, Wook
    Kim, Hyoung-Il
    Kim, Hyung-Ho
    Ryu, Seung Wan
    Hur, Hoon
    Kong, Seong-Ho
    Cho, Gyu Seok
    Kim, Jin-Jo
    Park, Do Joong
    Ryu, Keun Won
    Kim, Young Woo
    Kim, Jong Won
    Lee, Joo-Ho
    Kim, Min-Chan
    ANNALS OF SURGERY, 2019, 270 (06) : 983 - 991
  • [44] Adjuvant oxaliplatin plus S-1 (SOX) with concurrent radiotherapy versus SOX alone for gastric cancer with D2 lymph node dissection and high risk factors: a randomized phase III trial
    Wang, X.
    Shen, Y.
    Li, Q.
    Qiu, M.
    Li, Z.
    Liu, J.
    Gou, H.
    Yang, Y.
    Cao, D.
    Yi, C.
    Luo, D.
    Zhu, H.
    Zhou, Z.
    Tan, S.
    Wang, W.
    Ye, X.
    Su, X.
    Xu, F.
    Bi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
    Kang, Yoon-Koo
    Yook, Jeong Hwan
    Park, Young-Kyu
    Lee, Jong Seok
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Park, Young Soo
    Son, Taeil
    Jung, Mi Ran
    Heo, Mi Hwa
    Kim, Hark Kyun
    Park, ChoHyun
    Yoo, Chang Hak
    Choi, Jin-Hyuk
    Zang, Dae Young
    Jang, You Jin
    Sul, Ji Young
    Kim, Jong Gwang
    Kim, Beom Su
    Beom, Seung-Hoon
    Cho, Sang Hee
    Ryu, Seung Wan
    Kook, Myeong-Cherl
    Ryoo, Baek-Yeol
    Kim, Hyun Ki
    Yoo, Moon-Won
    Lee, Nam Su
    Lee, Sang Ho
    Kim, Gyunji
    Lee, YeonJu
    Lee, Jee Hyun
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2903 - +
  • [46] A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)
    Tianshu, L.
    Yu, Y.
    Sun, Y.
    Min, Y.
    Cao, H.
    Yingbin, L.
    Wang, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Laparoscopic D2 plus complete mesogastrium excision using the "enjoyable space" approach versus conventional D2 total gastrectomy for local advanced gastric cancer: short-term outcomes
    Zheng, Chang-Yue
    Dong, Zhi-Yong
    Dong, Zhiyong
    Qiu, Xian-Tu
    Zu, Bin
    Xu, Rui
    Lin, Wei
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2020, 15 (01) : 58 - 69
  • [48] Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
    Hu, Xiang
    Chen, Lin
    Du, Yian
    Fan, Biao
    Bu, Zhaode
    Wang, Xin
    Ye, Yingjiang
    Zhang, Zhongtao
    Xiao, Gang
    Li, Fei
    He, Qingsi
    Li, Guoli
    Shen, Xian
    Xiong, Bin
    Zhu, Liming
    Liu, Jiwei
    Liu, Lian
    Wu, Tao
    Zhou, Jing
    Zhang, Jun
    Zhao, Gang
    Wang, Xulin
    Liang, Pin
    Wang, Xinxin
    Zhang, Yan
    Wu, Xiaojiang
    Zhang, Ji
    Ji, Xin
    Zong, Xianglong
    Fu, Tao
    Jia, Ziyu
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (02) : 144 - 148
  • [49] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
    Zhichao Jiang
    Yibin Xie
    Wen Zhang
    Chunxia Du
    Yuxin Zhong
    Yuelu Zhu
    Liming Jiang
    Lizhou Dou
    Kang Shao
    Yongkun Sun
    Qi Xue
    Yantao Tian
    Shugeng Gao
    Dongbing Zhao
    Aiping Zhou
    Gastric Cancer, 2024, 27 : 571 - 579
  • [50] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
    Jiang, Zhichao
    Xie, Yibin
    Zhang, Wen
    Du, Chunxia
    Zhong, Yuxin
    Zhu, Yuelu
    Jiang, Liming
    Dou, Lizhou
    Shao, Kang
    Sun, Yongkun
    Xue, Qi
    Tian, Yantao
    Gao, Shugeng
    Zhao, Dongbing
    Zhou, Aiping
    GASTRIC CANCER, 2024, 27 (03) : 571 - 579
12345